NEUCA S.A. (WSE:NEU)

Market Cap	3.01B -17.3%
Revenue (ttm)	13.64B +8.2%
Net Income	155.58M +0.9%
EPS	34.05 +0.1%
Shares Out	4.51M
PE Ratio	19.62
Forward PE	16.35
Dividend	16.00 (2.25%)
Ex-Dividend Date	Jul 15, 2025

Volume	1,569
Average Volume	1,170
Open	661.00
Previous Close	668.00
Day's Range	657.00 - 675.00
52-Week Range	636.00 - 857.00
Beta	0.37
RSI	23.50
Earnings Date	Mar 26, 2026

About NEUCA

NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Activities segments. The company offers Rx, OTC drugs, dietary supplements, medical devices, dermocosmetics, hygiene products, personal protective equipment, as well as diagnostic and dressing materials under the Świat Zdrowia, APTEO, GENOPTIM, CERA+ Solutions, and Kic Kic brands. It also provides medical care services, including p...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1990
• Employees: 4,445
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: NEU

Financial Performance

In 2025, NEUCA's revenue was 13.64 billion, an increase of 8.18% compared to the previous year's 12.61 billion. Earnings were 155.58 million, an increase of 0.87%.